1-[3-(TRIFLUOROMETHYL)PHENYL]CYCLOPROPANEMETHANAMINE, 95%, 5g

2-Bromo-6-fluoro-3-nitrobenzoic acid, 95.0%, 5g

Sal disódica de NADH, 1 g.

4-chloro-2,5,6-trimethylpyrimidine, 95.0%, 250mg

Pyrimidine-4,5,6-triamine, 95.0%, 1g

p-Hexyloxybromobenzene, 98.0%, 25g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, calibrada de fábrica, 0,01 g, 820 g, BCE822i-1CEU

2-((5-CHLOROPYRIDIN-2-YL)AMINO)-2-OXOACETIC ACID, 95.0%, 1g

2-Methyl-4-(2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)benzonitrile, 97%, 250mg

(3aR,6R,6aR)-6-(Hydroxymethyl)-2,2-dimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one, 97.0%, 5g

Butyraldehyde>98.0%(GC)500mL

2-Fluoroanisole>96.0%(GC)25mL

2-(3-Bromophenyl)-1,1,1-trifluoropropan-2-ol, 95%, 50mg